Related Experiment Videos

Successful chemotherapeutic decompression of primary endodermal sinus tumor presenting with severe spinal cord

F D Pashankar1, P Steinbok, G Blair

  • 1Division of Hematology/Oncology/Bone Marrow Transplantation, British Columbia Children's Hospital and University of British Columbia, Vancouver, Canada.

Insights

Cisplatin-based chemotherapy effectively treated spinal cord compression from endodermal sinus tumors (EST) in a child. This approach led to rapid symptom resolution and full neurologic recovery without surgery or radiation.

Area of Science:

  • Pediatric Oncology
  • Neurosurgery
  • Medical Imaging

Background:

  • Spinal cord compression in children can result from various tumors.
  • Primary paraspinal endodermal sinus tumors (EST) are rare but aggressive pediatric malignancies.
  • Management often involves a multimodal approach including surgery, radiation, and chemotherapy.

Observation:

  • A 17-month-old child presented with near-complete paraplegia due to a primary paraspinal EST causing spinal cord compression.
  • The tumor was compressing the spinal cord, leading to severe neurological deficits.

Findings:

  • The child received cisplatin-based chemotherapy as the primary treatment modality.
  • Laminectomy and radiation therapy were deliberately avoided.
  • Rapid resolution of paraplegia and complete neurologic recovery were observed.
  • Excellent tumor response to chemotherapy was achieved with no long-term sequelae.

Implications:

  • Chemotherapy alone can be a viable and effective alternative to laminectomy or radiation therapy for managing epidural spinal cord compression caused by EST.
  • This non-invasive approach offers a promising treatment strategy for pediatric patients with spinal cord compression from EST, potentially reducing treatment-related morbidity.
  • Further research into chemotherapy-alone protocols for similar cases is warranted to establish its efficacy and safety profile.

Related Concept Videos